University HealthSystem Consortium
Record ID 32000008215
Authors' objectives:

Reviews the progress of paclitaxel use since its introduction in 1992 as a first-line therapy in the treatment of advanced ovarian cancer. Also examines the use of paclitaxel as a single agent in treating breast, non-small cell lung cancers, AIDs-related Kaposi's sarcoma, as well as numerous off-label indications, including head and neck, esophageal, small-cell lung, endometrial, and bladder cancers. Also features a discussion of clinical trials pertaining to paclitaxel use and a survey administered to UHC members that shows wide variability in dose and infusion duration.

Authors' methods: Overview
Project Status: Completed
URL for project:
Year Published: 1999
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Antineoplastic Agents
  • Paclitaxel
  • Carcinoma, Small Cell
Organisation Name: University HealthSystem Consortium
Contact Address: University HealthSystem Consortium, 2001 Spring Rd., Suite 700, Oak Brook, IL 60523 USA. Tel: 630-954-1700, Fax: 630/954-4730
Contact Name:
Contact Email:
Copyright: University HealthSystem Consortium
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.